Poliomyelitis

sleep apnea congestive heart failure symptoms :: Article Creator Sleep Apnea And Its Hidden Dangers For Heart Health Published 12:30 pm Friday, April 4, 2025 By Dr. Jaisingh Rajput, MD  Sleep is essential for heart health, but millions of Americans unknowingly suffer from sleep apnea, a serious disorder that disrupts breathing during sleep. Obstructive Sleep Apnea (OSA) affects nearly 30 million adults, yet 80% remain undiagnosed.  Left untreated, sleep apnea significantly increases the risk of heart disease, high blood pressure, stroke, and sudden cardiac death. Understanding the connection between sleep apnea and heart health can save lives. If you or a loved one experience loud snoring, gasping for air at night, or excessive daytime sleepiness, it's time to seek medical evaluation. What Is Sleep Apnea? Sleep apnea is a disorder in which breathing repeatedly stops and starts during sleep due to an obstruction in t...

hape treatment :: Article Creator

reactive pulmonary hypertension :: Article Creator Dr. Roach: Hypertension Diagnosis Hasn't Been Discussed With Patient Your browser is not supporteddetroitnews.Com detroitnews.Com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use. Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on detroitnews.Com

lung function test at home :: Article Creator Routine Asthma Test More Reliable In Morning And Has Seasonal Effects, Say Doctors A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, Cambridge researchers have found. Using real world data from 1,600 patients, available through a database created for speeding up research and innovation, the team also found that its reliability differs significantly in winter compared to autumn. Asthma is a common lung condition that can cause wheezing and shortness of breath, occasionally severe. Around 6.5% of people over six years old in the UK are affected by the condition. Treatments include the use of inhalers or nebulisers to carry medication into the lungs. The majority of asthma attacks occur at nighttime or early in the morning. Although this may in part be due to cooler nighttime air and exposure to dust mites and allergens, i...

pah disease :: Article Creator Burden Of PAH Weighs Heavy Worldwide Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national burdens in pulmonary arterial hypertension (PAH). Female individuals and older adults, especially if they live in an economically disadvantaged sociodemographic index (SDI) area, are more likely to be adversely affected by pulmonary arterial hypertension (PAH), highlighting the ongoing burden of PAH despite an overall decline in age-standardized incidence rates (ASIRs) of this rare and progressive type of pulmonary hypertension and severe cardiovascular condition. PAH continues to present a significant, global health burden despite treatment and diagnosis advances, and its true impact on the 192,000 patients living with this condition remains a major global health threat.1 Data on incidence, prevalence, mortality rates, and disability-adjusted life-years (...

ase pulmonary hypertension :: Article Creator Managing Pulmonary Hypertension In Pregnancy Pulmonary arterial hypertension (PAH) can be a challenging complication to manage during pregnancy; women with PAH who are pregnant are considered a high-risk population, and they face higher rates of maternal and fetal complications. Close monitoring and individualizing treatment plans should be top priorities for the multidisciplinary teams caring for women who are pregnant or are considering pregnancy and exhibiting signs of pulmonary hypertension, according to new research published in International Journal of Cardiology Congenital Heart Disease.1 This patient population is known to have higher risks of maternal morbidity and mortality, in addition to poor fetal outcomes, and newer data indicate that individual prognosis may be dependent on underlying etiology, such as hemodynamic changes—or alterations in blood flow such as from a cardiovascular condi...

pulmonary valve disorder :: Article Creator Dr. Roach: Hypertension Diagnosis Hasn't Been Discussed With Patient Your browser is not supporteddetroitnews.Com detroitnews.Com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use. Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on detroitnews.Com Mitral Valve Stenosis Topic Review EtiologyPathophysiologySymptomsPhysical ExaminationDiagnosisTreatment Introduction The area of a normal mitral valve is 4 to 6 cm2. This area is sufficient to allow a great deal of blood to flow from the left atrium (LA) to the left ventricle. When any disease process decreases the mitral valve area, mitral stenosis (MS) develops. As mitral stenosis progresses over time, the pressure in the left atrium rises. T...

lung infection treatment :: Article Creator Advancing Pulmonary Care: How Clinical Trials At Temple Lung Center Are Shaping The Future The treatments of tomorrow often start as clinical trials today. And when it comes to groundbreaking advancements in pulmonary care, the Temple Lung Center is at the forefront, offering patients access to potential new treatments before they become widely available. The Temple Lung Center's robust research program typically offers at least 50 enrolling options for clinical trials, with many options focused on conditions that can severely impact lung function: chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), idiopathic pulmonary fibrosis (IPF), pulmonary embolism, pulmonary hypertension, mycobacterium infection, asthma, lung cancer, sarcoidosis, and more. Provided Courtesy/Temple Health Lung Center Dr. Aamir Ajmeri and Dr. Lijo C. Illipparambil, both physician-researchers at ...